Michelle Hebert, MD | |
504 Medical Center Blvd, Conroe, TX 77304-2808 | |
(713) 432-1100 | |
(713) 432-0221 |
Full Name | Michelle Hebert |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 34 Years |
Location | 504 Medical Center Blvd, Conroe, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043215098 | NPI | - | NPPES |
220023059 | Other | TX | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZH0000X | Pathology - Hematology | H9985 (Texas) | Primary |
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | H9985 (Texas) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Kingwood Medical Center | Kingwood, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Gulf Coast Pathology Program Pllc | 3476956194 | 29 |
News Archive
The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
A new study from scientists at The Scripps Research Institute shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine.
A healthy lifestyle intervention program administered at the workplace and developed by the University of Pittsburgh Graduate School of Public Health significantly reduces risk factors for diabetes and heart disease, according to a study reported in the March issue of the Journal of Occupational and Environmental Medicine.
Makdasi et al. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants. bioRxiv, 2021. doi: https://doi.org/10.1101/2021.04.01.438035, https://www.biorxiv.org/content/10.1101/2021.04.01.438035v2
› Verified 2 days ago
Entity Name | Gulf Coast Pathology Program Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629643069 PECOS PAC ID: 3476956194 Enrollment ID: O20210719002395 |
News Archive
The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
A new study from scientists at The Scripps Research Institute shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine.
A healthy lifestyle intervention program administered at the workplace and developed by the University of Pittsburgh Graduate School of Public Health significantly reduces risk factors for diabetes and heart disease, according to a study reported in the March issue of the Journal of Occupational and Environmental Medicine.
Makdasi et al. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants. bioRxiv, 2021. doi: https://doi.org/10.1101/2021.04.01.438035, https://www.biorxiv.org/content/10.1101/2021.04.01.438035v2
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Michelle Hebert, MD Po Box 4677, Houston, TX 77210-4677 Ph: () - | Michelle Hebert, MD 504 Medical Center Blvd, Conroe, TX 77304-2808 Ph: (713) 432-1100 |
News Archive
The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
A new study from scientists at The Scripps Research Institute shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine.
A healthy lifestyle intervention program administered at the workplace and developed by the University of Pittsburgh Graduate School of Public Health significantly reduces risk factors for diabetes and heart disease, according to a study reported in the March issue of the Journal of Occupational and Environmental Medicine.
Makdasi et al. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants. bioRxiv, 2021. doi: https://doi.org/10.1101/2021.04.01.438035, https://www.biorxiv.org/content/10.1101/2021.04.01.438035v2
› Verified 2 days ago
Anne S. Witson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
Emilie Rouah, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
Peter Allen Powaser, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
Jacqueline Elizabeth Monheit, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
David Houston Yawn, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
Mary Ostrowski, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 |